AMN Healthcare price target lowered to $87 from $92 at JMP Securities

JMP Securities lowered the firm’s price target on AMN Healthcare to $87 from $92 and keeps an Outperform rating on the shares. AMN executed well through a challenging 2023 across a number of fronts, given a historical reset within the industry on how contingent labor is used following outsized staffing demand during the pandemic, and JMP is encouraged by near-term rate commentary and the continued expansion of the company’s pipeline, the analyst tells investors in a research note.